...
机译:EGFR突变在原发性切除的非小细胞肺癌中缺乏预后价值
Division of Hematology and Oncology Department of Internal Medicine Mackay Memorial Hospital 92 ChungShan North Road Taipei 104 Taiwan;
Division of Hematology and Oncology Department of Internal Medicine Mackay Memorial Hospital 92 ChungShan North Road Taipei 104 Taiwan;
Mackay Medicine Nursing and Management College Taipei Taiwan;
Division of Chest Medicine Department of Internal Medicine Mackay Memorial Hospital Taipei Taiwan;
Department of Pathology Mackay Memorial Hospital Taipei Taiwan;
Division of Hematology and Oncology Department of Internal Medicine Mackay Memorial Hospital 92 ChungShan North Road Taipei 104 Taiwan;
Epidermal growth factor receptor; Mutation; Non-small cell lung cancer; Prognosis; Survival;
机译:外显子19的预后值与21例EGFR突变因手术切除的非小细胞肺癌腺癌的疾病阶段而异
机译:P3.03-29肿瘤突变负荷和吸烟病史在切除EGFR突变体非小细胞肺癌中的预后作用
机译:在E4592上原发切除的非小细胞肺癌中,p53和K-ras突变的预后意义不足:一项针对东部合作肿瘤小组的术后辅助治疗前瞻性随机试验的实验室辅助研究。
机译:手术切除的Ⅰ期非小细胞肺癌患者FDG摄取是复发的生物学预后因素
机译:TNFAIP8组合对非小细胞肺癌细胞EGFR和IGF-1R信号传导及靶向药物的细胞毒性的影响
机译:EGFR TKI在切除的非小细胞肺癌中的佐剂治疗与EGFR突变:所有闪闪发光的都不是黄金!
机译:P3.03-29肿瘤突变负荷和吸烟病史在切除EGFR突变体非小细胞肺癌中的预后作用